Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

28.32
+0.29891.07%
Post-market: 28.420.0957+0.34%19:49 EDT
Volume:274
Turnover:8K
Market Cap:1.42M
PE:- -
High:28.42
Open:28.42
Low:28.32
Close:28.03
52wk High:29.89
52wk Low:24.32
Shares:50.00K
Float Shares:50.00K
Volume Ratio:0.03
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Dow Jones
·
Sep 08

Abbvie : Bofa Global Research Raises Price Objective to $282.00 from $276.00

THOMSON REUTERS
·
Sep 08

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)

TIPRANKS
·
Sep 08

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Dow Jones
·
Sep 05

Estee Lauder Cos. Cl a Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 05

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbbVie (ABBV)

TIPRANKS
·
Sep 04

Scotiabank Remains a Buy on AbbVie (ABBV)

TIPRANKS
·
Sep 04

AbbVie Closes $10.9B Takeover of Apogee, Its Largest Deal Since 2019, With Earnings Lift Expected From 2032

Stock News
·
Sep 04

Estée Lauder CEOs De La Faverie, Shrivastava to Speak at Barclays Global Consumer Conference

Reuters
·
Sep 04

Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,458 Common Shares for $97,961.14

Reuters
·
Sep 04

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live
·
Sep 04

Analysts’ Top Healthcare Picks: Align Tech (ALGN), Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
Sep 03

Estee Lauder announces brand leadership appointments

TIPRANKS
·
Sep 03

Estée Lauder Names Justin Boxford Global President of Luxury Beauty Brands

Reuters
·
Sep 03

The EstÉE Lauder Companies Announces Brand Leadership Appointments

THOMSON REUTERS
·
Sep 03

AbbVie's Phase 3 Study of Etentamig in Multiple Myeloma Meets Dual Primary Endpoints

MT Newswires Live
·
Sep 03

AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study

Dow Jones
·
Sep 03

AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS

TIPRANKS
·
Sep 03

AbbVie's Blood Cancer Drug Meets Late-Stage Trial Goals

Reuters
·
Sep 03